DOHA: Three clinical studies among children with respiratory problems were discussed at a recent seminar at Qatar University (QU). The studies were held for babies aged 18 months and less with bronchiolitis and children with asthma, aged 2-14 years.
The Biomedical Research Centre (BRC) at QU hosted a seminar ‘Research in Paediatric Emergency Department – Hamad Medical Corporation (HMC),’ to inform QU Health Cluster researchers and academics about research activities running at the Paediatric Emergency Centre.
The seminar delivered by Prof Khaled Al Ansari, Director, Paediatric Emergency Centres, HMC, and Associate Professor of Clinical Paediatrics at Weill Cornell Medicine-Qatar (WCM-Q), brought together participants from the Health Cluster and HMC, Dr Asmaa Al Thani, Director, BRC, and Dean, College of Health Sciences, and other faculty and staff.
Prof Al Ansari briefed the audience on the five paediatric emergency centres in Qatar and services they provide to the community. He also spoke about the three clinical studies. He compared the efficiency of saline solution in pre-hospital treatment of acute bronchiolitis on the first study ‘Nebulised 5 percent or 3 percent Hypertonic or 0.9 percent Saline for the Treatment of Acute Infant Bronchiolitis: A Randomised Trial’.
“The study showed the importance of hypertonic saline nebulisation in the improvement of the severity of bronchiolitis in children suffering from viral bronchiolitis,” he said.
On the second study ‘Oral Dexamethasone for Bronchiolitis: A Randomised Trial’, he highlighted the effect of dexamethasone treatment administered with salbutamol for patients with bronchiolitis and asthma.
On the third study ‘Inhaled Magnesium for Moderate and Severe Paediatric Asthma: A Randomised Controlled Trial,’ he pointed to the efficiency of inhaled magnesium for the treatment of moderate and severe paediatric asthma. “The use of nebulised magnesium sulfate with combined nebulised bronchodilator and systemic steroids can be effective for the treatment of children with moderate or severe asthma,” he added.
The Peninsula
DOHA: Three clinical studies among children with respiratory problems were discussed at a recent seminar at Qatar University (QU). The studies were held for babies aged 18 months and less with bronchiolitis and children with asthma, aged 2-14 years.
The Biomedical Research Centre (BRC) at QU hosted a seminar ‘Research in Paediatric Emergency Department – Hamad Medical Corporation (HMC),’ to inform QU Health Cluster researchers and academics about research activities running at the Paediatric Emergency Centre.
The seminar delivered by Prof Khaled Al Ansari, Director, Paediatric Emergency Centres, HMC, and Associate Professor of Clinical Paediatrics at Weill Cornell Medicine-Qatar (WCM-Q), brought together participants from the Health Cluster and HMC, Dr Asmaa Al Thani, Director, BRC, and Dean, College of Health Sciences, and other faculty and staff.
Prof Al Ansari briefed the audience on the five paediatric emergency centres in Qatar and services they provide to the community. He also spoke about the three clinical studies. He compared the efficiency of saline solution in pre-hospital treatment of acute bronchiolitis on the first study ‘Nebulised 5 percent or 3 percent Hypertonic or 0.9 percent Saline for the Treatment of Acute Infant Bronchiolitis: A Randomised Trial’.
“The study showed the importance of hypertonic saline nebulisation in the improvement of the severity of bronchiolitis in children suffering from viral bronchiolitis,” he said.
On the second study ‘Oral Dexamethasone for Bronchiolitis: A Randomised Trial’, he highlighted the effect of dexamethasone treatment administered with salbutamol for patients with bronchiolitis and asthma.
On the third study ‘Inhaled Magnesium for Moderate and Severe Paediatric Asthma: A Randomised Controlled Trial,’ he pointed to the efficiency of inhaled magnesium for the treatment of moderate and severe paediatric asthma. “The use of nebulised magnesium sulfate with combined nebulised bronchodilator and systemic steroids can be effective for the treatment of children with moderate or severe asthma,” he added.
The Peninsula
